<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03137108</url>
  </required_header>
  <id_info>
    <org_study_id>2017-00053</org_study_id>
    <nct_id>NCT03137108</nct_id>
  </id_info>
  <brief_title>Effects of Transcutaneous Spinal Cord Stimulation on Residual Voluntary Motor Control in Individuals With Incomplete Spinal Cord Injury</brief_title>
  <official_title>Effects of Transcutaneous Spinal Cord Stimulation on Residual Voluntary Motor Control, Standing, and Overground Walking in Individuals With Incomplete Spinal Cord Injury Single Centre Pilot Study Investigating Immediate Effects of Transcutaneous Electrical Spinal Cord Stimulation on Voluntary Ankle and Knee Control, Standing and Overground Walking in Incomplete Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, a transcutaneous protocol of electrical spinal cord stimulation (tSCS) has been&#xD;
      developed. It was suggested, that this method could be used to improve the therapy process&#xD;
      after a spinal cord injury (SCI). The aim of this study is to investigate the immediate&#xD;
      effects of tSCS with different stimulation modalities on voluntary motor control in patients&#xD;
      with incomplete SCI.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Kinematic movement characteristics recorded with a motion capture system;</measure>
    <time_frame>Baseline and intervention of a specific task will be assessed directly after each other in a single session. All movement tasks will be split into 2 sessions within 2 weeks. The start of the first session is variable.</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Motor Control in Incomplete Spinal Cord Injured Persons</condition>
  <arm_group>
    <arm_group_label>Incomplete Spinal cord injury</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous electrical spinal cord stimulation</intervention_name>
    <description>Study intervention consists of the application of tSCS at three different frequencies (15 Hz, 30 Hz, 50 Hz) using the CE certified electrostimulator RehaMove 3. Stimulation will only be applied by an investigator during the two testing sessions. During the overground walking, the participants will be secured and assisted with the cable-driven body-weight support system FLOAT.</description>
    <arm_group_label>Incomplete Spinal cord injury</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with incomplete SCI&#xD;
&#xD;
          -  Chronic (≥ 12 months post-injury) or subacute (≥ 3 months post-injury) stage of&#xD;
             recovery&#xD;
&#xD;
          -  Age: ≥18 years&#xD;
&#xD;
          -  Able to complete the 10mWT with walking aids as required but no physical assistance&#xD;
&#xD;
          -  Neurological level of SCI: above T12&#xD;
&#xD;
          -  Preserved segmental and cutaneo-muscular reflexes in the lower limbs&#xD;
&#xD;
          -  Bodyweight &gt; 20 kg and &lt; 120 kg&#xD;
&#xD;
          -  Mini-Mental state examination score 6 (test only performed if cognitive deficits are&#xD;
             suspected)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any other neurological diseases&#xD;
&#xD;
          -  Current orthopedic problems&#xD;
&#xD;
          -  Premorbid major depression or psychosis&#xD;
&#xD;
          -  History of significant autonomic dysreflexia with treatment&#xD;
&#xD;
          -  Dermatological issues (e.g. decubitus) at the stimulation or harness attachment site&#xD;
             (back, abdomen, upper legs)&#xD;
&#xD;
          -  Active implants (e.g. cardiac pacemaker, implanted drug pump)&#xD;
&#xD;
          -  Passive implants at vertebral level T9 or more caudal vertebrae (metal screws and&#xD;
             plates for surgical stabilization of spinal fractures)&#xD;
&#xD;
          -  Malignant diseases&#xD;
&#xD;
          -  Heart insufficiency NYHA III-IV&#xD;
&#xD;
          -  Potential pregnancy (pregnancy test must be conducted before each session)&#xD;
&#xD;
          -  Unlikely to complete the intervention or return for follow-up&#xD;
&#xD;
          -  Participation in another training study&#xD;
&#xD;
          -  Contraindications for BWS training using the FLOAT (according the manual):&#xD;
&#xD;
          -  No responsiveness&#xD;
&#xD;
          -  Severe muscle contractures&#xD;
&#xD;
          -  Acute fractures&#xD;
&#xD;
          -  Osteoporosis or osteogenesis imperfecta&#xD;
&#xD;
          -  Body size shorter than 1 meter or taller than 2 meters&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universitätsklinik Balgrist</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 21, 2017</study_first_submitted>
  <study_first_submitted_qc>April 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2017</study_first_posted>
  <last_update_submitted>July 22, 2021</last_update_submitted>
  <last_update_submitted_qc>July 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

